Results 131 to 140 of about 3,412 (160)

Novel Non-hallucinogenic Neurite Growth Compounds as 5‑HT2A Agonists for Treating Stress-Related Disorders, Namely Depression, Anxiety, and PTSD. [PDF]

ACS Med Chem Lett
Sabnis RW.
europepmc   +1 more source

Gheorghe Marinescu's studies on the influence of mescaline on artistic creativity. [PDF]

Med Pharm Rep
Magurean ID, Sandor V, Dumitrascu DL.
europepmc   +1 more source

Hallucinogen Persisting Perception Disorder in a Young Adult Case Report. [PDF]

Case Rep Psychiatry
Notani S, Srinivasa V, Chaudhry S, Weiss A.   +3 more
europepmc   +1 more source

Psychedelics distinctly alter brain entropy and complexity compared to psychostimulants

Larsen K, Fisher PM, McCulloch DE, Olsen AS, Mueller F, Liechti M, Borgwardt S, Holze F, Vizeli P, Ley L, Klaiber A, Becker A, Ozenne B, Avram M.   +13 more
europepmc   +1 more source

U.S. Psychedelic Use and Microdosing in 2025: Insights from a Probability-Based and Nationally Representative Survey.

Rand Health Q
Priest M, Kilmer B, Senator B, Setodji CM.   +3 more
europepmc   +1 more source